Wanted: cutting-edge research ideas
Published on June 9, 2016

The Australian Type 1 Diabetes Clinical Research Network’s (T1DCRN) Innovation Award is now open for applications. The Request for Applications (RFA) Innovation Award is to fund and advance promising innovation that, if successful, would improve the lives of people with type 1 diabetes.  JDRF and the T1DCRN are seeking innovative proposals describing cutting-edge innovation falling […]

Link between early infections and type 1 diabetes 
Published on May 27, 2016

New JDRF-funded research published in the May issue of JAMA (The Journal of the American Medical Association) details evidence of a link between infections in early life and later development of type 1 diabetes (T1D). It has long been thought that there could be a link between common viral infections and the development of T1D. […]

Breaking free from the daily burden
Published on April 26, 2016

In Australia, our T1D community has been asking questions about The Human Trial — a feature-length documentary which takes the viewer inside the ViaCyte lab in San Diego with exclusive patient access. This is particularly as the profile of this work has been raised through the support of R&B star, Usher (dad to a son with […]

Fresh perspectives invigorate smart insulin research
Published on April 6, 2016

At JDRF we know it will take time, talent and passion to create a world without type 1 diabetes (T1D). So, we are committed to harnessing the intellect of emerging scientists and attracting the attention of more established researchers to the T1D space. Many of our research partners share this commitment, and combining our efforts […]

Researchers team up to speed encapsulation progress
Published on March 24, 2016

Recently, three JDRF-funded scientists joined forces to develop a potential encapsulated islet cell therapy for the treatment of type 1 diabetes (T1D). Collaboration among experts with different specialties can speed up research progress by uniting the brightest minds in pursuit of a common goal. Research newly-published in Nature Biotechnology and Nature Medicine, showcased the success […]

JDRF Australia welcomes research visitors
Published on March 15, 2016

JDRF Australia was delighted recently to welcome two visitors from The Leona M. and Harry B. Helmsley Charitable Trust, a U.S. private foundation whose assets see it ranked 14th in the world. The visitors are taking the opportunity to review the Australian research landscape, while working in partnership with JDRF Australia on a major Australian […]


A major discovery about how proinsulin might stimulate the development of type 1 diabetes (T1D) has been published this month in Science, one of the world’s top academic journals. JDRF is proudly among the bodies that funded this research, and supports three of the research paper’s co-authors, Alvin Powers, David Harlan and Australia’s own Stuart […]

Hitting the ‘on’ switch for smart insulin
Published on February 10, 2016

Calibr, the California Institute for Biomedical Research, is a unique interdisciplinary institute poised to create a ‘smart insulin’ that can better control glucose for people living with type 1 diabetes (T1D), in a project funded by JDRF. The new GRI adopts a different strategy than ever tried before: a novel antibody platform designed with a […]

Seeking common ground between T1D and MS
Published on December 1, 2015

MS Research Australia and JDRF Australia have co-awarded an innovative research fellowship for a new study looking for overlaps between two autoimmune diseases – multiple sclerosis (MS) and type 1 diabetes (T1D), thanks to a $150,000 grant from the Macquarie Group Foundation. Dr Grant Parnell, a young medical researcher at The Westmead Institute for Medical […]

1 6 7 8 9 10 12